lymphoplasmacytic lymphoma
Showing 26 - 35 of 35
Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)
Completed
- Follicular Lymphoma
- +3 more
-
Fullerton, California
- +40 more
Jun 14, 2019
Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Minneapolis (biological, drug, radiation)
Withdrawn
- Hematologic Malignancy
- +16 more
- Treg cells
- +5 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 29, 2017
Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma Trial in Seongnam, Seoul (Bortezomib)
Unknown status
- Waldenstrom Macroglobulinemia
- Lymphoplasmacytic Lymphoma
-
Seongnam, Korea, Republic of
- +1 more
Nov 6, 2017
Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma Trial in Paris (Chlorambucil,
Completed
- Waldenström Macroglobulinemia
- +2 more
-
Paris, FranceHôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital
Aug 18, 2015
Waldenstrom's Macroglobulinemia, Lymphoplasmacytic Lymphoma Trial in Boston (Thalidomide, Rituximab)
Completed
- Waldenstrom's Macroglobulinemia
- Lymphoplasmacytic Lymphoma
-
Boston, Massachusetts
- +1 more
May 8, 2014
Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia Trial in Boston (Campath-1H)
Completed
- Lymphoplasmacytic Lymphoma
- Waldenstrom's Macroglobulinemia
-
Boston, Massachusetts
- +2 more
Dec 19, 2012
Waldenstrom's Macroglobulinemia, Lymphoplasmacytic Lymphoma Trial in Boston (Bortezomib (Velcade))
Completed
- Waldenstrom's Macroglobulinemia
- Lymphoplasmacytic Lymphoma
- Bortezomib (Velcade)
-
Boston, Massachusetts
- +1 more
Jun 23, 2011